Todd Foley, Director, 10% Owner at Aktis Oncology, Inc. (AKTS), bought 2,921,140 shares at $18.00 ($4.2M) on 2026-01-12, disclosed to the SEC on 2026-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,688,270 | $0 | 0.0% |
| 2 | $18.00 | 232,870 | $4.2M | 100.0% |
| Total | $1.43 avg | 2,921,140 | $4.2M | 100% |
| Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |
| RPTX | SELL | 2021-06-30 | $495K | — | Filing → |